Abstract
LINGO4 is a leucine-rich repeat and immunoglobulin-like domain-containing transmembrane protein encoded immediately adjacent to Rorc, the gene for RORγt, raising the possibility that it contributes to the biology of RORγt+ lymphocytes. However, its impact on these cells and resistance to enteric infections has remained unknown. Here, we identify LINGO4 as a critical regulator of group 3 innate lymphoid cells (ILC3s). Lingo4−/− ILC3s exhibit a profound, cell-intrinsic defect in IL-22 production linked to impaired STAT3 activation, mitochondrial dysfunction, elevated ROS, and increased apoptosis. In vivo, Lingo4 deficiency also drives a dysbiotic gut microbiota, resulting in an additional, microbiota-dependent loss of ILC3s. These combined defects increase susceptibility to Clostridioides difficile and Citrobacter rodentium, whereas IL-22 reduction in Lingo4−/− mice confers protection against Salmonellatyphimurium. Immunoprecipitation of tagged LINGO4 reveals interaction networks enriched in mitochondrial pathways, providing mechanistic insight into its role in ILC3 metabolic fitness and intestinal immunity.
Funding Information
  • National Institutes of Health (S10 OD032131)
  • National Institutes of Health (WLC6313040077)
  • National Institutes of Health (R01DK126969)
  • National Institutes of Health (R01DK132327)
  • National Cancer Institute (#P30 CA91842)
  • Institute of Clinical and Translational Sciences
  • Clinical and Translational Science Award (UL1TR000448)
  • National Center for Research Resources
  • National Science Foundation (No. DBI-1827534)
  • Pew Charitable Trusts (00035299)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2017/06577-9)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2023/00393-4)

This publication has 72 references indexed in Scilit: